Form 10-Q · Quarterly report
CSX Corporation 10-Q, filed Jul 22, 2026
- Filed
- CIK
- 0000277948
- Accession no.
- 0000277948-26-000032
Summary
CSX Corporation filed its quarterly Form 10-Q for the second quarter of 2026, outlining its current operational risks, including concerns over labor difficulties and the inflation rate. The company also reported that its board authorized a new $5 billion share repurchase program, increasing its total remaining repurchase authority to $5.7 billion as of June 30, 2026.
Key points
- CSX Corporation concluded that its disclosure controls and procedures were effective as of June 30, 2026.
- The board of directors authorized a new $5 billion incremental share repurchase authority on May 12, 2026.
- The total remaining share repurchase authority as of June 30, 2026, was $5.7 billion.
- The company cited factors such as labor difficulties, real estate market conditions, and inflation as key operational risks.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS •labor and benefit costs and labor difficulties, including stoppages affecting either the Company's operations or customers' ability to deliver goods to the Company for shipment; •the Company's success in implementing its strategic, financial and operational initiatives, including acquisitions; •the impact of conditions in the real estate market on the Company's ability to sell assets; •changes in operating conditions and costs, including the impacts of inflation, or commodity concentrations; •the impacts of a public health crisis and any policies or initiatives instituted in response; …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.